title: Editorial commentary: New drugs for diabetes: Finally safety and cardiovascular efficacy.
authors.affiliation: Keenan Biomedical Research Centre, Li Ka Shing Knowledge Institute St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada. Electronic address: ConnellyK@smh.ca.
authors.forename: Kim A
authors.initials: KA
authors.lastname: Connelly
mesh_terms: D003924:Diabetes Mellitus, Type 2; D006801:Humans; D007004:Hypoglycemic Agents
chemical_list: D007004:Hypoglycemic Agents